BPC
OGN icon

Bryce Point Capital’s Organon & Co OGN Stock Holding History

Bryce Point Capital’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$275K Sell
25,758
-22,310
-46% -$219K 0.34% 145
2025
Q2 		$465K Buy
+48,068
New +$496K 0.39% 144

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Bryce Point Capital's OGN Position: Q3 2025 in Review

Bryce Point Capital reduced its Organon & Co (OGN) stake by 46% in Q3 2025, selling an estimated $219K and leaving 25,758 shares worth $275K. The position accounts for 0.34% of the portfolio, ranked #145.

Bryce Point Capital first reported a position in OGN in Q2 2025 and has held it in 2 quarters since. The position peaked at $465K in Q2 2025. 669 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

  • Bryce Point Capital held 25,758 shares of Organon & Co worth $275K as of Q3 2025.
  • Bryce Point Capital sold 22,310 Organon & Co shares in Q3 2025, an estimated $219K.
  • Organon & Co made up 0.34% of Bryce Point Capital's portfolio in Q3 2025, its #145 holding.
  • Bryce Point Capital first reported a position in Organon & Co in Q2 2025 and has held it in 2 quarters since.
  • Bryce Point Capital's Organon & Co position peaked at $465K in Q2 2025.
  • 669 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on Bryce Point Capital's 13F filing for Q3 2025, filed 6 Nov 2025.